Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults

Vaccine

Volumn 29, Issue 31, 2011, Pages 5015-5021

  Yao, Xu ^a   Hamilton, Robert G ^a   Weng, Nan ping ^c   Xue, Qian Li ^a   Bream, Jay H ^b   Li, Huifen ^a   Tian, Jing ^a   Yeh, Shu Hui ^f   Resnick, Barbara ^d   Xu, Xiyan ^e   Walston, Jeremy ^a   Fried, Linda P ^g   Leng, Sean X ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^g Columbia University Mailman School of Public Health ^*  (United States)

Author keywords

Antibody response; Frailty; Influenza immunization; Influenza infection; Influenza like illness; Older adults

Indexed keywords

INFLUENZA VACCINE;

AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLU LIKE SYNDROME; FRAIL ELDERLY; HEMAGGLUTINATION INHIBITION; HIGH RISK POPULATION; HUMAN; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SEASONAL INFLUENZA; TREATMENT RESPONSE; VACCINATION REACTION;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; FEMALE; FRAIL ELDERLY; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PROSPECTIVE STUDIES; VACCINES, INACTIVATED;

EID: 79959758526     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.077     Document Type: Article

References (45)

1. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292(September (11)):1333-1340.
2. Molinari N.A., Ortega-Sanchez I.R., Messonnier M.L., Thompson W.W., Wortley P.M., Weintraub E., et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25(June (227)):5086-5096.
3. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(January (2)):179-186.
4. Rivetti D., Jefferson T., Thomas R., Rudin M., Rivetti A., Di P.C., et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2006, 3:CD004876.
5. Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994, 272(December (21)):1661-1665.
6. Praditsuwan R., Assantachai P., Wasi C., Puthavatana P., Kositanont U. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. J Med Assoc Thai 2005, 88(2):256-264.
7. Murasko D.M., Bernstein E.D., Gardner E.M., Gross P., Munk G., Dran S., et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002, 37(January (2-3)):427-439.
8. McElhaney J.E., Ewen C., Zhou X., Kane K.P., Xie D., Hager W.D., et al. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009, 27(April (18)):2418-2425.
9. Nichol K.L., D'Heilly S.J., Greenberg M.E., Ehlinger E. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years. Clin Infect Dis 2009, 48(February (13)):292-298.
10. Nichol K.L., Nordin J., Mullooly J. Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons. Vaccine 2006, 24(March (10)):1562-1568.
11. Nichol K.L., Nordin J.D., Nelson D.B., Mullooly J.P., Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007, 357(October (14)):1373-1381.
12. Nichol K.L. Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. Vaccine 2009, 27(October (45)):6305-6311.
13. Simonsen L., Reichert T.A., Viboud C., Blackwelder W.C., Taylor R.J., Miller M.A. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005, 165(February (3)):265-272.
14. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007, 7(October (10)):658-666.
15. Simonsen L., Viboud C., Taylor R.J., Miller M.A., Jackson L. Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine 2009, 27(October (45)):6300-6304.
16. Jackson M.L., Nelson J.C., Weiss N.S., Neuzil K.M., Barlow W., Jackson L.A. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008, 372(August (9636)):398-405.
17. Jackson L.A., Nelson J.C., Benson P., Neuzil K.M., Reid R.J., Psaty B.M., et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006, 35(April (2)):345-352.
18. Fried L.P., Tangen C., Walston J., Newman A., Hirsch C.H., Gottdiener J.S., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56A(March (3)):M1-M11.
19. Fried L.P., Walston J. Frailty. Hazzard's principles of geriatric medicine and gerontology 2007, McGraw-Hill, Anne Arbor. 6th ed. J.B. Halter (Ed.).
20. Fried L.P., Hadley E.C., Walston J.D., Newman A., Guralnik J.M., Studenski S., et al. From bedside to bench: research agenda for frailty. Sci Aging Knowl Environ 2005, 2005(August (31)):e24.
21. Fried L.P., Xue Q.L., Cappola A.R., Ferrucci L., Chaves P., Varadhan R., et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A: Biol Sci Med Sci 2009, 64(October (10)):1049-1057.
22. Leng S.X., Xue Q.L., Tian J., Walston J.D., Fried L.P. Inflammation and frailty in older women. J Am Geriatr Soc 2007, 55(June (6)):864-871.
23. Fried L.P., Ferrucci L., Darer J., Williamson J.D., Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A: Biol Sci Med Sci 2004, 59(March (3)):255-263.
24. Makary M.A., Segev D.L., Pronovost P.J., Syin D., Bandeen-Roche K., Patel P., et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 2010, 210(June (6)):901-908.
25. Leng S., Chaves P., Koenig K., Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 2002, 50(July (7)):1268-1271.
26. Walston J., McBurnie M.A., Newman A., Tracy R., Kop W.J., Hirsch C.H., et al. Frailty and activation of the inflammation and coagulation systems with and without clinical morbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002, 162(November):2333-2341.
27. Leng S., Xue Q., Tian J. Association of neutrophil and monocyte counts with fraily in community-dwelling older women. Exp Gerontol 2009, (44):511-516.
28. Qu T., Walston J.D., Yang H., Fedarko N.S., Xue Q.L., Beamer B.A., et al. Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14(+) monocytes in frail older adults. Mech Ageing Dev 2009, 130(March (3)):161-166.
29. Semba R.D., Margolick J.B., Leng S., Walston J., Ricks M.O., Fried L.P. T cell subsets and mortality in older community-dwelling women. Exp Gerontol 2005, 40(January (1-2)):81-87.
30. De F.U., Wang G.C., Fedarko N.S., Walston J.D., Casolaro V., Leng S.X. T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults. J Am Geriatr Soc 2008, 56(May (5)):904-908.
31. Yao X., Li H., Leng S.X. Inflammation and immune system alterations in frailty. Clin Geriatr Med 2011, 27(February (1)):79-87.
32. Leng S.X., Cappola A.R., Andersen R.E., Blackman M.R., Koenig K., Blair M., et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 2004, 16(April (2)):153-157.
33. Bennett N.M. Diagnosis of influenza. Med J Aust 1973, (June (Suppl. 22)).
34. Dolin R., Reichman R.C., Madore H.P., Maynard R., Linton P.N., Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982, 307(September (10)):580-584.
35. McElhaney J.E., Hooton J.W., Hooton N., Bleackley R.C. Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. Vaccine 2005, 23(May (25)):3294-3300.
36. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. Center for Disease Control and Prevention 2009, 11th ed. Washington, DC: Public Health Foundation; 2009. Available from: URL: http://www.cdc.gov/vaccines/pubs/pinkbook/.
37. Beyer W.E., Palache A.M., Baljet M., Masurel N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 1989, 7(October (5)):385-394.
38. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24(February (8)):1159-1169.
39. Gravenstein S., Drinka P., Duthie E.H., Miller B.A., Brown C.S., Hensley M., et al. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J Am Geriatr Soc 1994, 42(March (3)):245-251.
40. Shahid Z., Kleppinger A., Gentleman B., Falsey A.R., McElhaney J.E. Clinical and immunologic predictors of influenza illness among vaccinated older adults. Vaccine 2010, 28(August (38)):6145-6151.
41. Roos-Van Eijndhoven D.G., Cools H.J., Westendorp R.G., Ten Cate-Hoek A.J., Knook D.L., Remarque E.J. Randomized controlled trial of seroresponses to double dose and booster influenza vaccination in frail elderly subjects. J Med Virol 2001, 63(4):293-298.
42. Iorio A.M., Camilloni B., Basileo M., Neri M., Lepri E., Spighi M. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. Gerontology 2007, 53(6):411-418.
43. Dean A.S., Moffatt C.R., Rosewell A., Dwyer D.E., Lindley R.I., Booy R., et al. Incompletely matched influenza vaccine still provides protection in frail elderly. Vaccine 2010, 28(January (3)):864-867.
44. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006, 176(May (10)):6333-6339.
45. Gijzen K., Liu W.M., Visontai I., Oftung F., van der W.S., Korsvold G.E., et al. Standardization and validation of assays determining cellular immune responses against influenza. Vaccine 2010, 28(April (19)):3416-3422.